Endothelin-1 (ET-1) concentration in patients with ischaemic heart failure;Stėzenie endoteliny 1 (ET-1) u chorych z niewydolnościa serca o etiologii niedokrwiennej

Folia Cardiologica

Volumn 10, Issue 2, 2003, Pages 169-175

  Nessler, Jadwiga ^a   Piwowarska, Wiesława ^a   Nessler, Bohdan ^a   Kitliński, Mariusz ^b   Mroczek Czernecka, Danuta ^a   Stepniewski, Marek ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Uniwersytet w Luna   (Poland)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Endothelin 1; Heart failure; Left ventricular function; Prognosis

Indexed keywords

ENDOTHELIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HUMAN; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROGNOSIS; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE;

EID: 0038782261     PISSN: 15074145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nohria A., Lewis E., Stevenson L.W. Medical managment of advanced heart failure. JAMA 2002; 287: 628-640.
2. Packer M., Cohn J.N. Consensus recommendations for the management of chronic heart failure. Am. J. Cardiol. 1999; 83: 1A-38A.
3. Korewicki J., Rywik S., Rywik T. Management of heart failure patients in Poland. Eur. J. Heart Fail. 2002; 4: 215-219.
4. Sabbach H.N., Sharov V.G. Apoptosis in heart failure. Prog. Cardiovasc. Dis. 1998; 40: 549-562.
5. Cohn J.N. Structural basis for heart failure: ventricular remodeling and its pharmacologic inhibition. Circulation 1995; 91: 2504-2507.
6. Negrusz-Kawecka M. Udział endotelin w schorzeniach układu krȧzenia. Pol. Merk. Lek. 2001; 11: 444-446.
7. Rodeheffer R.J., Lerman A., Heublein D.M. i wsp. Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin. Proc. 1992; 67: 719-724.
8. Selavis P.L., Robert A., van Linden F., Ketelslegers i wsp. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure. J. Card. Fail. 2000; 6: 201-307.
9. Isnard R., Pousset F., Trochu J. i wsp. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure. Am. J. Cardiol. 2000; 86: 417-421.
10. Ferrara R., Mastrorilli F., Pasanisi G. i wsp. Neurohormonal modulation in chronic heart failure. Eur. Heart J. 2002; 23 (supl. D): D3-D11.
11. Spieker L.E., Noll G., Rutschitzka F.T., Luscher T.F. Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future. J. Am. Coll. Cardiol. 2001; 37: 1493-1505.
12. Myszka W., Kara-Perz H., Torliński L. Endotelina-1 w chorobie niedokrwiennej serca. Pol. Merk. Lek. 2001; 11: 291-294.
13. Schiffrin E.L., Intengan H.D., Thibault G., Tonyz R.M. Clinical significance of endothelin in cardiovascular disease. Cur. Op. Cardiol. 1997; 12: 354-367.
14. Kohno M., Yokokawa K., Yasunari K. i wsp. Effect of the endothelin family of peptides on human coronary artery smooth-muscle cell migration. J. Cardiovasc. Pharmacol. 1998; 31: S84-S89.
15. Knofer R., Urano T., Malyszko J. i wsp. In vitro effect of endothelin-1 on collagen and ADP-induced aggregation in human whole blood and platelet rich plasma. Thromb. Res. 1995; 77: 69-78.
16. Joannides R., Haefeli W.E., Linder L. i wsp. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vitro. Circulation 1995; 91: 1314-1319.
17. Kiowski W., Sutsch G., Hunziker P. i wsp. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 1995; 346: 732-736.
18. Monge J.C. Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? J. Cardiovasc. Pharmacol. 1998; 32 (supl. 2): S36-S42.
19. Pousset F., Isnard R., Lechat P. i wsp. Prognostic of plasma endothelin-1 in patients with chronic heart failure. Eur. Heart J. 1997; 18 (2): 254-258.
20. Collucci W., Braunwald E. Patophysiology of heart failure. W: Braunwald E., Zipes D.P., Libby P. red. Heart disease. A textbook of cardiovascular medicine. W.B. Saunders Company 2001; 503-533.